ICD-10 Code A30.1 | Tuberculoid leprosy Symptoms, Diagnosis, Billing

Tuberculoid leprosy, caused by Mycobacterium leprae, is a chronic infectious disease characterized by skin lesions and peripheral nerve damage. It is clinically significant due to its potential for disability and social stigma. Accurate coding with ICD-10 Code A30.1 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate treatment and resource allocation.

What is ICD-10 Code A30.1 for Tuberculoid leprosy?

ICD-10 Code A30.1 represents Tuberculoid leprosy, a form of leprosy that presents with localized skin lesions and nerve involvement. This code should be used when documenting cases of Tuberculoid leprosy in clinical settings, ensuring accurate billing and compliance with health regulations. It is crucial for tracking the incidence and prevalence of this condition.

ICD-10 Code A30.1 – Clinical Definition and Explanation of Tuberculoid leprosy

Tuberculoid leprosy is caused by the bacterium Mycobacterium leprae, leading to a localized immune response. The condition progresses slowly and can result in significant morbidity if untreated. Medical attention is necessary to manage symptoms and prevent complications.

Key Clinical Features:

• Presence of hypopigmented skin lesions with well-defined borders.
• Nerve damage leading to loss of sensation and muscle weakness.
• Possible involvement of peripheral nerves, resulting in motor deficits.
• Low bacterial load in skin lesions, indicating a strong immune response.

ICD-10 Code A30.1 for Tuberculoid leprosy – SOAP Notes & Clinical Use

ICD-10 Code A30.1 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of Tuberculoid leprosy. It plays a vital role in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code A30.1 for Tuberculoid leprosy Mean in SOAP Notes?

In SOAP notes, ICD-10 Code A30.1 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Tuberculoid leprosy. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code A30.1 – Tuberculoid leprosy

Tuberculoid leprosy requires prompt medical intervention to prevent complications and manage symptoms effectively.

Antibiotic Therapy:

• Rifampicin: 600 mg once monthly.
• Dapsone: 100 mg daily.
• Clofazimine: 300 mg once monthly and 50 mg daily.

Supportive Care:

• Regular monitoring of skin lesions and nerve function.
• Physical therapy to maintain muscle strength.
• Psychosocial support to address stigma and mental health.

Infection Control:

• Educate patients on hygiene practices.
• Avoid close contact with untreated individuals.
• Implement isolation measures during outbreaks.

How to Document Symptoms of Tuberculoid leprosy (ICD-10 A30.1) in SOAP Notes

Subjective:

• Patient reports numbness and tingling in hands and feet.
• History of skin lesions appearing over the past few months.
• Complaints of muscle weakness in affected areas.
• Patient expresses concern about social stigma.

Objective:

• Hypopigmented skin lesions noted on examination.
• Decreased sensation in affected areas on monofilament testing.
• Muscle strength testing reveals weakness in hand grip.
• No signs of systemic infection or fever.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Tuberculoid leprosy (ICD-10 Code A30.1)

Assessment:

• Diagnosis: Tuberculoid leprosy (ICD-10 A30.1).
• Severity: Mild, with localized skin lesions and nerve involvement.
• Contributing factors: Possible exposure to untreated leprosy cases.

Plan:

• Initiate treatment with Rifampicin and Dapsone.
• Schedule follow-up appointments for monitoring.
• Provide patient education on disease management and stigma.

Treatment & Plan Section for ICD-10 Code A30.1 – Tuberculoid leprosy

• First-line pharmacologic treatments include Rifampicin and Dapsone.
• Non-pharmacologic strategies involve physical therapy and psychosocial support.
• Monitoring includes regular assessments of skin lesions and nerve function.
• Follow-up practices should be scheduled every 1-3 months.

Using ICD-10 Code A30.1 for Tuberculoid leprosy in Billing & SOAP Note Compliance

• Select accurate subcodes based on clinical severity or complications.
• Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
• Ensure treatment plans align with clinical guidelines to support justified billing.
• Only list CPT codes that are commonly billed with ICD-10 Code A30.1.

Related ICD-10 Codes Often Used with Tuberculoid leprosy

• A30.0 – Lepromatous leprosy
• A30.9 – Leprosy, unspecified
• B90.0 – Sequelae of leprosy

ICD-10 Code A30.1 in Medical Billing and Insurance for Tuberculoid leprosy

ICD-10 Code A30.1 is critical for billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Ensure detailed documentation of symptoms and treatment plans.
• Use the code in conjunction with relevant CPT codes for accurate billing.
• Document patient education and follow-up plans to support claims.

Common CPT Pairings: